117 related articles for article (PubMed ID: 22530846)
1. Structural insight for imidazopyridazines as malarial kinase PfPK7 inhibitors using QSAR techniques.
Sahu NK; Kohli DV
Med Chem; 2012 Jul; 8(4):636-48. PubMed ID: 22530846
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and in vitro evaluation of imidazopyridazines as novel inhibitors of the malarial kinase PfPK7.
Bouloc N; Large JM; Smiljanic E; Whalley D; Ansell KH; Edlin CD; Bryans JS
Bioorg Med Chem Lett; 2008 Oct; 18(19):5294-8. PubMed ID: 18774709
[TBL] [Abstract][Full Text] [Related]
3. Molecular modelling studies for the discovery of new substituted pyridines derivatives with angiotensin II AT1 receptor antagonists.
Sharma MC
Interdiscip Sci; 2014 Sep; 6(3):197-207. PubMed ID: 25205497
[TBL] [Abstract][Full Text] [Related]
4. 2D and 3D QSAR models for identifying diphenylpyridylethanamine based inhibitors against cholesteryl ester transfer protein.
Chen M; Yang X; Lai X; Gao Y
Bioorg Med Chem Lett; 2015 Oct; 25(20):4487-95. PubMed ID: 26346366
[TBL] [Abstract][Full Text] [Related]
5. 3D-QSAR and molecular docking studies on pyrazolopyrimidine derivatives as glycogen synthase kinase-3beta inhibitors.
Dessalew N; Patel DS; Bharatam PV
J Mol Graph Model; 2007 Mar; 25(6):885-95. PubMed ID: 17018257
[TBL] [Abstract][Full Text] [Related]
6. QSAR studies on 3-(4-biphenylmethyl) 4, 5-dihydro-4-oxo-3H-imidazo [4, 5-c] Pyridine derivatives as angiotensin II (AT1) receptor antagonist.
Sharma MC
Interdiscip Sci; 2015 Jun; 7(2):113-28. PubMed ID: 26215494
[TBL] [Abstract][Full Text] [Related]
7. 3D-QSAR and Molecular Docking Studies on Oxadiazole Substituted Benzimidazole Derivatives: Validation of Experimental Inhibitory Potencies Towards COX-2.
Asati V; Ghode P; Bajaj S; Jain SK; Bharti SK
Curr Comput Aided Drug Des; 2019; 15(4):277-293. PubMed ID: 30280671
[TBL] [Abstract][Full Text] [Related]
8. Combined 3D-QSAR modeling and molecular docking study on indolinone derivatives as inhibitors of 3-phosphoinositide-dependent protein kinase-1.
AbdulHameed MD; Hamza A; Liu J; Zhan CG
J Chem Inf Model; 2008 Sep; 48(9):1760-72. PubMed ID: 18717540
[TBL] [Abstract][Full Text] [Related]
9. Molecular modeling studies on benzimidazole carboxamide derivatives as PARP-1 inhibitors using 3D-QSAR and docking.
Zeng H; Zhang H; Jang F; Zhao L; Zhang J
Chem Biol Drug Des; 2011 Sep; 78(3):333-52. PubMed ID: 21585709
[TBL] [Abstract][Full Text] [Related]
10. 3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum.
Kumari M; Chandra S; Tiwari N; Subbarao N
BMC Struct Biol; 2016 Aug; 16():12. PubMed ID: 27534744
[TBL] [Abstract][Full Text] [Related]
11. Structure-based QSAR, molecule design and bioassays of protease-activated receptor 1 inhibitors.
Zhong W; Liu P; Zhang Q; Li D; Lin J
J Biomol Struct Dyn; 2017 Oct; 35(13):2853-2867. PubMed ID: 27809674
[TBL] [Abstract][Full Text] [Related]
12. Identification of the Structural Features of Guanine Derivatives as MGMT Inhibitors Using 3D-QSAR Modeling Combined with Molecular Docking.
Sun G; Fan T; Zhang N; Ren T; Zhao L; Zhong R
Molecules; 2016 Jun; 21(7):. PubMed ID: 27347909
[TBL] [Abstract][Full Text] [Related]
13. QSAR, docking and ADMET studies of artemisinin derivatives for antimalarial activity targeting plasmepsin II, a hemoglobin-degrading enzyme from P. falciparum.
Qidwai T; Yadav DK; Khan F; Dhawan S; Bhakuni RS
Curr Pharm Des; 2012; 18(37):6133-54. PubMed ID: 22670592
[TBL] [Abstract][Full Text] [Related]
14. Molecular modeling and structure-activity relationships for a series of benzimidazole derivatives as cruzain inhibitors.
Pauli I; Ferreira LG; de Souza ML; Oliva G; Ferreira RS; Dessoy MA; Slafer BW; Dias LC; Andricopulo AD
Future Med Chem; 2017 May; 9(7):641-657. PubMed ID: 28509592
[TBL] [Abstract][Full Text] [Related]
15. PfPK7, an atypical MEK-related protein kinase, reflects the absence of classical three-component MAPK pathways in the human malaria parasite Plasmodium falciparum.
Dorin D; Semblat JP; Poullet P; Alano P; Goldring JP; Whittle C; Patterson S; Chakrabarti D; Doerig C
Mol Microbiol; 2005 Jan; 55(1):184-96. PubMed ID: 15612927
[TBL] [Abstract][Full Text] [Related]
16. Insight into the structural requirements of benzothiadiazine scaffold-based derivatives as hepatitis C virus NS5B polymerase inhibitors using 3D-QSAR, molecular docking and molecular dynamics.
Zhang HX; Li Y; Wang X; Xiao ZT; Wang YH
Curr Med Chem; 2011; 18(26):4019-28. PubMed ID: 21824089
[TBL] [Abstract][Full Text] [Related]
17. A QSAR analysis of 2-phenoxy-N-substituted acetamide analogues as hypoxia-inducible factor-1(HIF-1) inhibitors: a rational approach to anticancer drug design.
Noolvi MN; Patel HM; Kamboj S
Med Chem; 2012 Jul; 8(4):599-614. PubMed ID: 22530909
[TBL] [Abstract][Full Text] [Related]
18. Quantitative structure-activity relationship study on BTK inhibitors by modified multivariate adaptive regression spline and CoMSIA methods.
Xu A; Zhang Y; Ran T; Liu H; Lu S; Xu J; Xiong X; Jiang Y; Lu T; Chen Y
SAR QSAR Environ Res; 2015; 26(4):279-300. PubMed ID: 25906044
[TBL] [Abstract][Full Text] [Related]
19. 3D-QSAR and docking studies on a series of benzothiadiazine derivatives as genotype 1 HCV polymerase inhibitors.
Patil VM; Gupta SP; Samanta S; Masand N
Med Chem; 2012 Nov; 8(6):1099-107. PubMed ID: 22779799
[TBL] [Abstract][Full Text] [Related]
20. Structure-based quantitative structure-activity relationship studies of checkpoint kinase 1 inhibitors.
Du J; Xi L; Lei B; Lu J; Li J; Liu H; Yao X
J Comput Chem; 2010 Nov; 31(15):2783-93. PubMed ID: 20839304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
